Genetic susceptibility to atherosclerosis. 1990

J C Chamberlain, and D J Galton
Department of Human Genetics and Metabolism, St. Bartholomew's Hospital, London, UK.

Genetic factors are implicated in atherogenesis by family and twin studies of coronary artery disease, interacting with the environment to produce the phenotypic disease. Restriction fragment length polymorphisms provide useful linkage markers with which to study the genetics of this disease, the effectiveness of marker loci being characterized in terms of their polymorphism information content. Other forms of nucleotide variation, including variable number of tandem repeats can also provide linkage markers for aetiological loci and can be detected by the use of polymerase chain amplification followed by sequencing, denaturing gel electrophoresis, base pair specific chemical cleavage or the use of oligonucleotide probes. Linkage markers may be used either in population association or familial studies. Candidate genes may be studied or complete genomic mapping attempted. A review of potential candidate genes for atherosclerosis is presented.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses

Related Publications

J C Chamberlain, and D J Galton
September 1989, Circulation,
J C Chamberlain, and D J Galton
January 2012, Stroke research and treatment,
J C Chamberlain, and D J Galton
May 2000, Circulation research,
J C Chamberlain, and D J Galton
December 1989, Bulletin of the New York Academy of Medicine,
J C Chamberlain, and D J Galton
January 1982, Arteriosclerosis (Dallas, Tex.),
J C Chamberlain, and D J Galton
July 2012, Molecular nutrition & food research,
J C Chamberlain, and D J Galton
January 1987, Genetic epidemiology,
J C Chamberlain, and D J Galton
January 1995, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!